apprized < approach < approached

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by approach

Number of relevant bibliographic references: 466.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000070 (2020)	Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique]	What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
000147 (2020)	Calvin J. Gordon [Canada] ; Egor P. Tchesnokov [Canada] ; Joy Y. Feng [États-Unis] ; Danielle P. Porter [États-Unis] ; Matthias Götte [Canada]	The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
000185 (2020)	Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde]	Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
000195 (2020)	Denis C. Bauer [Australie] ; Aidan P. Tay [Australie] ; Laurence O W. Wilson [Australie] ; Daniel Reti [Australie] ; Cameron Hosking [Australie] ; Alexander J. Mcauley [Australie] ; Elizabeth Pharo [Australie] ; Shawn Todd [Australie] ; Vicky Stevens [Australie] ; Matthew J. Neave [Australie] ; Mary Tachedjian [Australie] ; Trevor W. Drew [Australie] ; S S Vasan [Australie]	Supporting pandemic response using genomics and bioinformatics: a case study on the emergent SARS-CoV-2 outbreak.
000218 (2020)	Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]	Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000290 (2020)	Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]	Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
000339 (2020)	Marissa L. Zwald ; Wen Lin ; Gail L. Sondermeyer Cooksey ; Charles Weiss ; Angela Suarez ; Marc Fischer ; Brandon J. Bonin ; Seema Jain ; Gayle E. Langley ; Benjamin J. Park ; Danielle Moulia ; Rory Benedict ; Nang Nguyen ; George S. Han	Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.
000388 (2020)	Qing-Xia Ma [République populaire de Chine] ; Hu Shan [République populaire de Chine] ; Hong-Liang Zhang [République populaire de Chine] ; Gui-Mei Li [République populaire de Chine] ; Rui-Mei Yang [République populaire de Chine] ; Ji-Ming Chen [République populaire de Chine]	Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2.
000413 (2020)	A. Pacifico [Italie] ; M. Ardig [Italie] ; P. Frascione [Italie] ; G. Damiani [Italie] ; A. Morrone [Italie]	Phototherapeutic approach to dermatological patients during the 2019 Coronavirus pandemic: Real-life Data from the Italian Red Zone.
000441 (2020)	Henry Ji [États-Unis] ; Ying Yan [États-Unis] ; Beibei Ding [États-Unis] ; Wenzhong Guo [États-Unis] ; Mark Brunswick [États-Unis] ; Andreas Niethammer [États-Unis] ; Williams Soohoo [États-Unis] ; Robin Smith [États-Unis] ; Alexis Nahama [États-Unis] ; Yanliang Zhang [États-Unis]	Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus.
000448 (2020)	Nicholas D. Brownstone [États-Unis] ; Quinn G. Thibodeaux [États-Unis] ; Vidhatha D. Reddy [États-Unis] ; Bridget A. Myers [États-Unis] ; Stephanie Y. Chan [États-Unis] ; Tina Bhutani [États-Unis] ; Wilson Liao [États-Unis]	Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
000453 (2020)	Anja Holm	New paths for sustainable solutions to tackle global and emerging infectious threats
000461 (2020)	Praveen Chandrasekharan [États-Unis] ; Maximo Vento [Espagne] ; Daniele Trevisanuto [Italie] ; Elizabeth Partridge [États-Unis] ; Mark A. Underwood [États-Unis] ; Jean Wiedeman [États-Unis] ; Anup Katheria [États-Unis] ; Satyan Lakshminrusimha [États-Unis]	Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed SARS-CoV-2 Infection.
000474 (2020)	Paolo Calligari [Italie] ; Sara Bobone [Italie] ; Giorgio Ricci [Italie] ; Alessio Bocedi [Italie]	Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
000477 (2020)	Hasan Mandal [Turquie]	Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic
000482 (2020)	Ashok K. Shetty	Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia
000543 (2020)	Kristin Tolksdorf [Allemagne] ; Silke Buda [Allemagne] ; Ekkehard Schuler [Allemagne] ; Lothar H. Wieler [Allemagne] ; Walter Haas [Allemagne]	Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19).
000559 (2020)	Bhumi Shah [Inde] ; Palmi Modi [Inde] ; Sneha R. Sagar [Inde]	In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.
000566 (2020)	Vargab Baruah [Inde] ; Sujoy Bose [Inde]	Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
000579 (2020)	Young Sup Shin [Corée du Sud] ; Dnyandev B. Jarhad [Corée du Sud] ; Min Hwan Jang [Corée du Sud] ; Kristina Kovacikova [Pays-Bas] ; Gyudong Kim [Corée du Sud] ; Ji-Seong Yoon [Corée du Sud] ; Hong-Rae Kim [Corée du Sud] ; Young Eum Hyun [Corée du Sud] ; Amol S. Tipnis [Corée du Sud] ; Tong-Shin Chang [Corée du Sud] ; Martijn J. Van Hemert [Pays-Bas] ; Lak Shin Jeong [Corée du Sud]	Identification of 6'-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication.
000619 (2020)	Michael Letko [États-Unis] ; Andrea Marzi [États-Unis] ; Vincent Munster [États-Unis]	Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "approach" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "approach" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    approach
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021